BeginnerActive

Psilocybin Therapy and the Rise of Existential Medicine

This article explains psilocybin therapy and the current research around its use in mental health care. It focuses on how clinical studies are structured, what participants can expect, and the possible benefits and limitations of treatment.

Provider

Double Blind

English

Schedule

Next cohort: Dec 1, 2026

30 days

Enrollment

Price on request

Decision Summary

Best fit
Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.
Format
Not listed
Time commitment
30 days
Credential signal
CME

Upcoming Cohort

Start date: December 1, 2026

Course Overview

Psilocybin Therapy and the Rise of Existential Medicine examines the renewed scientific interest in psilocybin after decades of limited research. The article draws on a conversation with Dr. Charles Grob to explain how psilocybin therapy is being studied for conditions such as substance use disorder, treatment-resistant depression, and other hard-to-treat psychological conditions. It also describes the typical structure of a psilocybin clinical trial, including screening, preparatory sessions, supervised dosing in a controlled setting, and the use of placebo-controlled, double-blind methods. The piece is intended for readers who want a clear overview of psilocybin-assisted psychotherapy and the practical realities of current research. The content is informational rather than instructional and reflects the legal and scientific limits of access to psilocybin therapy in most places.

Who is this for?

Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.

About the Provider

DoubleBlind is a biannual print magazine and digital media company covering psychedelics and related topics including mental health and environmental justice. Its site says it began as a print magazine and now publishes journalism, offers classes and workshops, and runs a monthly membership programme focused on harm reduction education and community.

View all Double Blind courses

Course FAQ

Who is this course for?

Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.

What is the format and time commitment?

Time commitment: 30 days.

How much does it cost?

The listed price is Price on request. Confirm the latest tuition, fees, and payment options on the provider website.

Does it offer a certificate or CE/CME credit?

The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.

When does the next cohort start?

The listed next cohort date is 2026-12-01.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses